Ensign Peak Advisors’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-123,750
| Closed | -$589K | – | 1758 |
|
|
2023
Q2 | $589K | Buy |
123,750
+24,300
| +24% | +$116K | ﹤0.01% | 1583 |
|
|
2023
Q1 | $567K | Buy |
99,450
+33,800
| +51% | +$193K | ﹤0.01% | 1612 |
|
|
2022
Q4 | $662K | Buy |
65,650
+45,400
| +224% | +$458K | ﹤0.01% | 1498 |
|
|
2022
Q3 | $454K | Hold |
20,250
| – | – | ﹤0.01% | 1510 |
|
|
2022
Q2 | $502K | Hold |
20,250
| – | – | ﹤0.01% | 1454 |
|
|
2022
Q1 | $785K | Hold |
20,250
| – | – | ﹤0.01% | 1337 |
|
|
2021
Q4 | $1.19M | Buy |
+20,250
| New | +$1.19M | ﹤0.01% | 1185 |
|
|
2021
Q3 | – | Sell |
-7,039
| Closed | -$611K | – | 1858 |
|
|
2021
Q2 | $611K | Sell |
7,039
-13,078
| -65% | -$1.14M | ﹤0.01% | 1558 |
|
|
2021
Q1 | $1.66M | Sell |
20,117
-12,617
| -39% | -$1.04M | ﹤0.01% | 1196 |
|
|
2020
Q4 | $2.98M | Sell |
32,734
-16,188
| -33% | -$1.47M | 0.01% | 836 |
|
|
2020
Q3 | $1.96M | Buy |
48,922
+43,740
| +844% | +$1.75M | ﹤0.01% | 984 |
|
|
2020
Q2 | $178K | Hold |
5,182
| – | – | ﹤0.01% | 1593 |
|
|
2020
Q1 | $115K | Sell |
5,182
-9,091
| -64% | -$202K | ﹤0.01% | 1568 |
|
|
2019
Q4 | $279K | Buy |
+14,273
| New | +$279K | ﹤0.01% | 1597 |
|